Emergent BioSolutions, Inc.
is expected to add 25 jobs at its Lansing plant after landing a $107 million contract from the federal government to produce the anthrax vaccine.
According to excerpts from the article:
Emergent expects to add about 25 jobs related to the contract through early 2011 and continue hiring after that, said Adam Havey, president of Emergent's Lansing operations.
"This is a huge step forward for us in utilizing our assets here in Lansing," Havey said. "It's a great sign of growth and innovation - not just locally, but as our company grows globally it solidifies us as a manufacturing center of excellence."
Emergent said Wednesday it signed a contact with the U.S. Department of Health and Human Services worth $54.6 million during the first two years, with options for three more years.
The company said it expects to see up to $10 million in revenue and $5 million in earnings before taxes in the second half of this year because of the contract.
Read the full article here.